Background--Few published studies have evaluated the power of the oxygen uptake efficiency slope (OUES) to predict outcomes in patients with idiopathic pulmonary arterial hypertension (IPAH), who typically die of right-sided heart failure. Our study sought to evaluate the power of OUES to predict clinical worsening and mortality in patients with IPAH.
P ulmonary arterial hypertension (PAH) is a devastating disease characterized by increased remodeling of pulmonary vasculature that leads to right-sided heart failure and death. It is important to identify patients with a higher risk of poor outcome early in order to treat them with optimal drugs, such as initial combination therapy for patients with a higher risk of mortality. 1 Several key parameters obtained from cardiopulmonary exercise testing (CPET), including peak oxygen uptake (peak _ VO 2 ), end tidal partial pressure of carbon dioxide at anaerobic threshold, ventilation ( _ VE)/ carbon dioxide output ( _ VCO 2 ) slope or ratio at anaerobic threshold, and heart rate recovery have been widely used to assess disease severity, therapeutic responses, and prognosis estimation in patients with PAH. 2, 3 In recent years, the oxygen uptake efficiency slope (OUES), representing the rate of increase in oxygen uptake ( _ VO 2 ) in response to a 10-fold increase in ventilation ( _ VE) during incremental exercise ( _ VO 2 ¼ a log _ VE+b; a=OUES), has been introduced by Baba et al. 4, 5 The advantages of OUES are that it can be calculated from submaximal exercise data and it is stable even when 50%, 75%, or 100% of the exercise data are used for the calculation. In addition, it is independent of interobserver and intraobserver variability. 6 Tan et al 7 demonstrated that OUES was significantly lower in patients with idiopathic PAH (IPAH) compared with that in healthy controls. Woods et al 8 showed that OUES was able to differentiate between patients with mild and severe pulmonary hypertension. 8 Only one study, with a relatively small number of patients, has shown that OUES was a better predictor than _ VE= _ VCO 2 slope and peak _ VO 2 and could predict poor outcome in 98 patients with PAH. Among them, 48 patients had IPAH and 50 patients had PAH with associated conditions. 9 It is still controversial whether OUES is better than the _ VE= _ VCO 2 slope for predicting adverse events in patients with left-sided heart failure. 10, 11 Recently, time to clinical worsening (CW) has become a better primary end point for randomized controlled trials in patients with PAH 12, 13 ; however, no study has evaluated the value of OUES in predicting CW in patients with IPAH. Therefore, the aim of this study was to assess the prognostic value of OUES for CW and mortality in patients with IPAH.
Methods

Study Participants
Consecutive adult patients with newly diagnosed IPAH admitted to Fuwai Hospital were prospectively enrolled from November 11, 2010 
Cardiopulmonary Exercise Testing
Symptom-limited CPET was performed using the COSMED Quark CPET system on all recruited patients with IPAH at baseline, before they received specific drug therapy. All patients rested for 3 minutes followed by 3 minutes of unloaded pedaling and exercise using a progressively increasing work rate of 5 to 20 WÁmin À1 (the rate of increasing work rate depended on the estimated exercise capacity of each patient) to a maximum tolerance on an electromagnetically braked cycle ergometer. Cardiac rhythm, measured by a standard 12-lead ECG, and oxyhemoglobin saturation were continuously recorded. Heart rate was recorded at 1-minute intervals. Blood pressure was measured every 3 minutes and at the peak of the exercise. The test was performed by experienced medical staff, and the equipment was calibrated before each test.
Calculation of CPET Measures
Gas exchange variables were measured by a metabolic cart (COSMED) on a breath-by-breath basis and averaged over 10-second intervals. Peak _ VO 2 was defined as the highest 30-second average of oxygen consumption in the last minute of exercise. Other peak values were also calculated at the same time point. Anaerobic threshold was determined by the Vslope method and corroborated using other plots. Peak _ VO 2 / heart rate was calculated as peak _ VO 2 divided by peak heart rate. Since previous studies show that _ VE= _ VCO 2 slope calculated using the whole exercise period, as opposed to from the start of exercise to the ventilatory compensation point in patients with left-sided heart failure and PAH, has better prognostic value, 11, 15, 16 _ VE= _ VCO 2 slope was determined by linear regression using the whole exercise period. OUES was determined by the slope of the regression line between log 10 minute ventilation _ VE (x axis, LÁmin À1 ) and _ VO 2 (y axis, LÁmin À1 ) during the whole exercise period ( _ VO 2 ¼ a log _ VE+b; a=OUES). A higher OUES (steeper slope) represents more efficient oxygen being delivered in the body; while a lower OUES (more flat slope) represents a higher amount of ventilation required in response to a given oxygen uptake ( Figure 1A and 1B) . 4 18, 19 Heart rate recovery was calculated as maximum heart rate-postexercise heart rate after 2 minutes during the recovery period.
Other Measures
Right-sided heart catheterization with standard hemodynamic measurements was performed at baseline within 3 days of each patient's CPET study, as we previously reported. 20 NT-
Clinical Perspective
What is New?
• In this study, we demonstrated that oxygen uptake efficiency slope, a submaximal parameter, is more strongly associated with clinical worsening and all-cause mortality than minute ventilation/carbon dioxide output slope, and peak oxygen consumption in patients with idiopathic pulmonary arterial hypertension.
What are the Clinical Implications?
• Oxygen uptake efficiency slope appears to be one of the strongest prognostic markers among exercise variables obtained from cardiopulmonary exercise testing in patients with idiopathic pulmonary arterial hypertension.
proBNP (N-terminal prohormone brain natriuretic peptide) was determined at baseline using an enzyme immunoassay kit (Biomedica Medizinprodukte GmbH&CoKG).
Follow-Up
Patients were followed-up every 3 months for 1 year, then every 6 months after they were discharged. WHO-FC, medications and side effects, the date and cause of lung transplantation, and death were documented at each followup. The end point of mortality was defined as all-cause mortality or lung transplantation. The end point of CW was defined as the time from CPET to the first event, which included the following: all-cause mortality, lung transplantation, hospitalization for worsening of PAH, the need for epoprostenol therapy, and interventional procedures (performance of balloon atrial septostomy). 12, 21 If patients experienced CW before death or lung transplantation, they were included in the analyses of both mortality and CW. The followup time was calculated from the date of CPET to the end point date or May 1, 2016.
Statistical Analysis
Continuous variables were expressed as meanAESD and categorical variables as a number or percentage as appropriate. Comparisons between groups were performed using independent-samples Student t tests or 1-way ANOVA for normally distributed variables and Mann-Whitney U test for non-normally distributed variables. Chi-square test was used for categorical variables. Multiple linear regression analysis (stepwise) was performed to assess the association between OUES and independent variables, which included age, sex, height, weight, body surface area (BSA), and body mass index. Correlations between 2 variables were explored using either the Pearson or Spearman correlation coefficient as appropriate. A Cox proportional hazards regression analysis was used to detect predictors associated with CW and survival. The variables predictive of CW and survival by univariate analysis (P<0.05) were then entered into a multivariable Cox regression analysis with a forward procedure (likelihood ratio) to determine independent predictors of CW and survival. Since there were not enough events, in order to avoid overfitting, for CW, we put only WHO-FC, NT-proBNP, pulmonary vascular resistance (PVR) cardiac index, peak _ VO 2 =kg, OUESI, _ VE= _ VCO 2 slope, heart rate recovery, and peak systolic blood pressure into the multivariable forward stepwise Cox analysis, and for mortality, we put only NT-proBNP, PVR, peak _ VO 2 =kg, OUESI, and _ VE= _ VCO 2 slope into the multivariable forward stepwise Cox analysis, considering both P values of the variable in univariate Cox analysis and their clinical significance.
Receiver operator characteristic curve analysis was used to identify the cutoff point for parameters associated with CW and survival, using data censored to 10 months (the shortest duration of follow-up in our study). Kaplan-Meier survival charts were created to determine differences in the rate of cardiac events between patients with values above or below the cutoff point. Curves were compared using the log-rank test. A 2-sided P<0.05 was considered statistically significant. Receiver operator characteristic curve analysis was performed using MedCalc for Windows, version 13.0 (MedCalc Software), and other statistical analyses were performed using SPSS version 19.0 (SPSS, Inc).
Results
Baseline Characteristics
A total of 213 patients were identified with IPAH and underwent CPET. Three patients were lost to follow-up and not included in the analysis. The mean age was 32AE10 years, and 75.7% of patients were women. A total of 112 patients presented with WHO-FC I and II, and 98 patients presented with WHO-FC III and IV. The mean Anaerobic threshold could not be identified in 17 patients. Twenty-one patients were treated with calcium channel blockers, 182 patients were treated with monotherapy (7 patients with prostacyclins, 33 patients with endothelin receptor antagonists, and 142 patients with phosphodiesterase type 5 inhibitors), and 7 patients were treated with combination therapy. The median duration of follow-up was 41AE15 months. During the follow-up period, 31 patients 
Differences in Variables Between Groups
Patients with subsequent CW had a similar sex distribution, age, BSA, and body mass index compared with patients without subsequent CW (non-CW). However, patients with subsequent CW had a poorer WHO-FC, higher NT-proBNP, and much more severe hemodynamic parameters. In addition, patients who presented with CW had significantly lower peak _ VO 2 , OUES, end tidal partial pressure of carbon dioxide at anaerobic threshold, heart rate recovery, and peak systolic blood pressure, along with higher _ VE= _ VCO 2 slope. There was no difference in the peak respiratory exchange ratio between patients with and without subsequent CW. These results also apply to the comparison between survivors and nonsurvivors (Table 1) . 
Oxygen Uptake Efficiency Slope
Predictors for Long-Term Outcomes
On univariate analysis, WHO-FC, NT-proBNP, and variables obtained from right-sided heart catheterization and CPET, except for age and sex, were all significant predictors of CW and mortality ( The specificity and sensitivity for predicting CW and mortality and the area under the receiver operator characteristic curve (AUC) for each variable are shown in Table 3 . The AUC for OUESI was higher than the _ VE= _ VCO 2 slope and peak _ VO 2 =kg for predicting both CW and mortality. The AUC for the percent-predicted OUES was lower than OUES for predicting both CW and mortality. In addition, the AUC for the percent- 
Discussion
In this study, we evaluated the prognostic value of exercise parameters obtained from CPET and hemodynamic parameters from right-sided heart catheterization and NT-proBNP. We found that the value of OUES fell with worsening symptoms and correlated well with peak _ VO 2 in patients with IPAH. In addition, the results of our present study found that OUESI, which was superior to peak _ VO 2 =kg and _ VE= _ VCO 2 slope, was an independent prognostic marker of mortality and CW among exercise parameters in patients with IPAH. AT indicates anaerobic threshold; HR, hazard ratio; HRR, heart rate recovery; mPAP, mean pulmonary arterial pressure; NT-proBNP, N-terminal prohormone brain natriuretic peptide; OUES, oxygen uptake efficiency slope; OUESI, oxygen uptake efficiency slope index (OUES/body surface area); PETCO 2 @AT, end tidal partial pressure of carbon dioxide at anaerobic threshold; PVR, pulmonary vascular resistance; RAP, right atrial pressure; SBP, systolic blood pressure; _ VCO 2 , carbon dioxide output; _ VE, minute ventilation; _ VO 2 , oxygen consumption; WHO-FC, World Health Organization functional class.
OUES, a submaximal exercise parameter, represents the absolute rate of increase in oxygen consumption per 10-fold increase in ventilation. It indicates how effectively the oxygen was extracted and utilized. Three main factors can affect OUES: (1) arterial pCO 2 (CO 2 set point), (2) metabolic carbon dioxide production, (3) physiologic pulmonary dead space ventilation. 4, 17 Sullivan and Cobb 22 demonstrated that the arterial carbon dioxide set point did not differ during exercise between patients with heart failure and normal individuals. Therefore, the distribution of blood to the skeletal muscles (systemic perfusion) determining the production of carbon dioxide and the perfusion to the lungs determining pulmonary dead space ventilation can both affect OUES. OUES is obviously resistant to foreshortening of exercise duration, which makes it useful in the assessment of patients who are unable to perform maximal exercise. 6 While peak _ VO 2 is a maximal exercise parameter, patients with low peak _ VO 2 can be underestimated because of lack of motivation and premature termination of exercise by the examiner. Previous studies showed that OUES was strongly correlated with peak _ VO 2 and provided greater prognostic information over peak _ VO 2 in patients with left-sided heart failure. 10, 23, 24 These results were consistent with the results of our study conducted in patients with IPAH. With respect to the _ VE= _ VCO 2 slope, Arena et al 11 demonstrated that the _ VE= _ VCO 2 slope was superior to OUES in predicting major cardiac-related events in patients with leftsided heart failure. However, Davies et al 10 found that log OUES, rather than peak _ VO 2 and _ VE= _ VCO 2 slope, was the most powerful prognostic marker from his study of 243 patients with left-sided heart failure and a median of 9 years of follow-up. The proportion of b-blocker use and the length of the tracking period may account for the difference. However, a study conducted in patients with PAH still found that OUES was the strongest independent prognostic marker, better than the _ VE= _ VCO 2 slope. 9 The _ VE= _ VCO 2 slope relates to physiologic pulmonary dead space and indicates the status of pulmonary perfusion. OUES reflects not only the status of pulmonary perfusion but also systemic perfusion, which may be the reason why OUES provides prognostic information that is superior to that provided by the _ VE= _ VCO 2 slope. 9 However, patients with PAH and its associated conditions were also included in their study population, in addition to 48 patients with IPAH. In fact, Deboeck et al 13 demonstrated that exercise variables obtained from a CPET were less accurate predictors of outcome in associated PAH because of inhomogeneity of the study population. Therefore, our result may be more representative when it is applied to patients with IPAH. When OUES was corrected for BSA, it had greater power than OUES in predicting CW and mortality; however, when the predicted values for OUES were calculated according to the equations of Hollenberg and Tager, the predictive power of percent-predicted OUES was not greater than OUES. This may have been attributable to the differences in study populations between the different studies. 6, 25 The mean value of OUES in patients with IPAH in our study and other studies were obviously lower than that in patients with left-sided heart failure (0.72-1.08 versus 1.60-1.96). 7,9-11 These results
were consistent with the results from our previous studies, 26, 27 which showed that patients with right-sided heart failure had worse exercise capacity compared with patients with left-sided heart failure.
Study Limitations
Exercise variables that predict survival in patients with IPAH cannot predict survival in patients with associated PAH 13 ;
therefore, our results only apply to patients with IPAH. Future studies need to explore whether OUES can also predict outcomes in patients with associated PAH. In addition, the sample size of our study was relatively small, and this may have led to the insignificant differences in AUC between the OUESI, _ VE= _ VCO 2 slope, and peak _ VO 2 =kg. A multicenter, large-scale study will be needed to validate these findings.
Conclusions
CPET provides excellent prognostic information in patients with IPAH. OUES, as an objective submaximal measure of cardiorespiratory fitness, appears to be one of the strongest prognostic markers among exercise variables for predicting CW and mortality.
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